- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 125,770 | 19.07.24 03:00:27 | +1,560 | +1,26% | 121,500 | 125,750 | 125,300 | 125,770 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 99,760 | 19.07.24 22:02:00 | +0,890 | +0,90% | 99,760 | 100,040 | 99,190 | 99,760 |
